Antibiotic Activity of P. aeruginosa Against MRSA and Candida albicans

• Published in: Kansenshogaku Zasshi Vol. 76; no. 4; pp. 231 - 237
• Main Authors: KONDO, Shigemi, SATO, Naotake, YAMADA, Toshihiko, MIYAZAKI, Sakiko, OGURI, Toyoko, IGARI, Jun
• Format: Journal Article
• Language: Japanese; English
• Published: Japan The Japanese Association for Infectious Diseases 01.04.2002
• Subjects: Antibiosis; bacterial interference; Candida albicans; Candida albicans - physiology; Methicillin Resistance; MRSA; Pseudomonas aeruginosa; Pseudomonas aeruginosa - physiology; Staphylococcus aureus - drug effects; Staphylococcus aureus - isolation & purification
• ISSN: 0387-5911; 1884-569X
• DOI: 10.11150/kansenshogakuzasshi1970.76.231

The antibiotic activity demonstrated by P. aeruginosa (Bacillus pyocyaneus) has been reported more than one hundred years ago by Emmerich et al (1899). Studies on such bacterial interference between P. aeruginosa and other pathogenic bacteria or fungi have not been extensively reported in recent years. In this paper, we report on the anti MRSA activity and anti Candida activity demonstrated by clinical isolates of P. aeruginosa (34 strains). The antibiotic activity was tested by reversed agar plate method, as previously reported, and the degree of the activity was expressed as the diameter of the zone of growth inhibition. The stability of both anti MRSA activity and anti Candida activity was evaluated at the time after 24 and 48-hr incubation. Also the effect of agar plate with or without 5% sheep blood on antibiotic activity was evaluated. Strong anti MRSA activity and anti Candida activity was shown at the time after 24-hr incubation. At the time after 48-hr incubation, anti MRSA activities were significantly suppressed but anti Candida activities were persisted. The inhibitory activity was correlated with dye production of P. aeruginosa. Some strains having non or weak dye production, showed the inhibitory activity by 48-hr incubation. Result from these strains without suppression of and Candida activity by additional blood may suggest that the existence of a new factor produced by P. aeruginosa. Because of frequent isolation of MRSA or Candida from clinical materials, we must consider bacterial flora and bacterial interference against pathogenic bacteria at the time of the antibiotic choice for the patients infected or colonized with P. aeruginosa.